Literature DB >> 19885577

Genetic and molecular alterations associated with oral squamous cell cancer (Review).

Mario Pérez-Sayáns1, José M Somoza-Martín, Francisco Barros-Angueira, María D Reboiras-López, José M Gándara Rey, Abel García-García.   

Abstract

The development of oral squamous cell cancer (OSCC) is a multistep process involving the accumulation of multiple genetic alterations modulated by genetic pre-disposition and environmental influences such as tobacco and alcohol use, chronic inflammation, and viral infections. All of these factors can lead to a wide range of genetic and molecular alterations that can be detected using a range of molecular studies. The alterations mostly affect two large groups of genes: oncogenes and tumor suppressor genes, which can be either inactivated or overexpressed through mutations, loss of heterozygosity, deletions, or epigenetic modifications such as methylation. Other molecules that are closely associated with tumor pathogenesis and prognosis also exist and warrant further study. Important advances in molecular biology are helping to shed light on oral cancer and thus aiding in the early diagnosis and development of new personalized treatment approaches. The purpose of the review is to explore the genetic and molecular alterations associated with OSCC.

Entities:  

Mesh:

Year:  2009        PMID: 19885577     DOI: 10.3892/or_00000565

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  38 in total

1.  Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

Authors:  Haibin Lu; Baolei Wu; Ge Ma; Deyu Zheng; Ruijuan Song; Erjiang Huang; Ming Mao; Bin Lu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.

Authors:  Kaushik Kumar Dey; Ipsita Pal; Rashmi Bharti; Goutam Dey; B N Prashanth Kumar; Shashi Rajput; Aditya Parekh; Sheetal Parida; Priyanka Halder; Indranil Kulavi; Mahitosh Mandal
Journal:  Tumour Biol       Date:  2015-07-11

3.  Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.

Authors:  Liang Ding; Bing Li; Ying Zhao; Yi-Fu Fu; Er-Ling Hu; Qin-Gang Hu; Yan-Hong Ni; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2014-07-25

4.  Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma.

Authors:  Hua Zhang; Lei Zhao; Ying-Xue Wang; Mian Xi; Shi-Liang Liu; Li-Ling Luo
Journal:  Tumour Biol       Date:  2015-06-10

5.  Contribution of LATS1 and LATS2 promoter methylation in OSCC development.

Authors:  Mohammad Ayoub Rigi Ladiz; Maryam Najafi; Dor Mohammad Kordi-Tamandani
Journal:  J Cell Commun Signal       Date:  2016-10-19       Impact factor: 5.782

Review 6.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

7.  S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.

Authors:  K K Dey; R Bharti; G Dey; I Pal; Y Rajesh; S Chavan; S Das; C K Das; B C Jena; P Halder; J G Ray; I Kulavi; M Mandal
Journal:  Cancer Gene Ther       Date:  2016-10-21       Impact factor: 5.987

8.  Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma.

Authors:  Shailaja K Rao; Zoran Pavicevic; Ziyun Du; Jong-Gwan Kim; Meiyun Fan; Yan Jiao; Molly Rosebush; Sandeep Samant; Weikuan Gu; Lawrence M Pfeffer; Christopher A Nosrat
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

9.  p53 as a prognostic marker associated with the risk of mortality for oral squamous cell carcinoma.

Authors:  Tommaso Cutilli; Pietro Leocata; Vincenza Dolo; Emma Altobelli
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

10.  Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.

Authors:  Roberto A Lleras; Richard V Smith; Leslie R Adrien; Nicolas F Schlecht; Robert D Burk; Thomas M Harris; Geoffrey Childs; Michael B Prystowsky; Thomas J Belbin
Journal:  Clin Cancer Res       Date:  2013-07-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.